Quest acquisition broadens market share
|
DEALS |
|||
|
WHO |
WITH |
WHAT |
SCOOP |
|
Quest Diagnostics |
LabOne |
$934M buyout |
The deal expands Quest's penetration of the market for health screening and risk assessment services. |
|
Meda |
Viatris |
€750M acquisition |
The deal creates a big player in the European specialty pharma field. |
|
Nektar Therapeutics |
Aerogen |
$32M buyout |
The acquisition broadens Nektar's pulmonary delivery capabilities by adding advanced inhaleable liquid drug technology to Nektar's base. |
|
GeoPharma |
Consolidated Pharmaceutical |
Asset acquisition |
GeoPharma gains a controlling interest in an antibiotic manufacturing facility. |
|
Pfizer |
Bioren |
Acquisition |
The acquisition of Bioren strengthens Pfizer's commitment to the antibody space. |
|
Paladin Labs |
Dimethaid Health Care |
Acquisition |
Paladin gains control of Pennsaid, a lotion approved by Health Canada for the treatment of symptoms of knee osteoarthritis. |